BioThera Solutions

EV Science, Translated for Clinicians.

The exosome skincare market is growing fast, and so is the noise. Dermatology clinics are increasingly expected to make informed decisions about EV-based products, but the field moves faster than most clinical education can keep up with. These resources exist to close that gap: practical, evidence-grounded tools built on the same standards used by the scientists who set them.

Evaluating EV or exosome products for your clinic? Start here.

A five-criteria evaluation framework: source, particle concentration, batch-specific Certificate of Analysis, isolation method and cold chain. Everything a clinic needs to evaluate EV material before stocking or recommending it.

The EV SELECT GUIDE
01Verify Particle ConcentrationFree

The EV SELECT GUIDE

A Clinician's Framework for Evaluating Extracellular Vesicle (EV/Exosome) Products

Your patients are already asking about exosome treatments. Do you have a reliable way to tell the real science from the marketing?

The EV/exosome skincare market is flooded with bold claims and inconsistent products. This guide gives dermatology clinicians a clear, science-backed framework to vet any EV supplier, covering the questions to ask, the data to demand, and the red flags to avoid.

Raising the Standard in a Noisy Category

The EV and exosome product market is expanding rapidly across brands, sources, and claims. Without standardization, clinicians are left to navigate a landscape where particle counts are unverified, sourcing is opaque, and marketing language outpaces the science. Knowing what to ask, regardless of which product or supplier, is the first line of defence for any clinic.

Browse by Category

Categories

Coming Soon

EV Characterization 101

What Clinicians Should Ask

Key questions every clinic should ask before stocking an EV product: particle count, size distribution, CoA requirements, and storage protocols.

Coming Soon

Communicating EV Science to Patients

A Plain-Language Guide for Clinicians

Practical language and frameworks for explaining extracellular vesicle biology, sourcing, and expected outcomes to patients, without overpromising or misrepresenting the current evidence base.

BioThera Solutions

A fully integrated extracellular vesicle company, from research and intellectual property to manufacturing at scale. Extracellular vesicles (EVs/exosomes) are among biology's most promising delivery systems, and we are building the infrastructure the field has been missing.

Ottawa, Ontario, Canada
477-150 Louis-Pasteur Private Ottawa, Ontario K1N 6N5 Canada

© 2026 BioThera Solutions Inc. All rights reserved.

For informational purposes only. Nothing on this website is medical advice. BioThera develops and manufactures characterized extracellular vesicles (exosomes) and, for cosmetic applications, licenses its technology exclusively to Vesera™, a skincare company. Vesera™ products are cosmetics and are not intended to diagnose, treat, cure, or prevent any disease. BioThera does not sell products to consumers, and its work on therapeutic applications is research only.